2 results
Approved WMOCompleted
The aim of this study is to assess the safety and efficacy of the new CaptivatorTM EMR kit.
Approved WMOCompleted
Primary Objective & HypothesisIn subjects with first line (1L) stage IV MSI-H or dMMR CRC treated with first line (1L) pembrolizumab (MK-3475) versus SOC chemotherapies,Objective: To compare Progression Free Survival (PFS) per RECIST 1.1 by…